Literature DB >> 20561689

Fighting cancers from within: augmenting tumor immunity with cytokine therapy.

Marc Pellegrini1, Tak W Mak, Pamela S Ohashi.   

Abstract

The human immune system has successfully evolved to fight many pathogens. Through vaccination, we can harness and improve immune responses to eradicate infections. Despite this success, we are only now beginning to understand the natural tumor immune surveillance mechanisms and why, in some instances, our immune system fails to abrogate the development and growth of tumors. Encouraging results with the latest immunotherapies have renewed enthusiasm in the field. A central component of these therapies is the contribution of cytokines. Here we review our expanding knowledge of cytokine-induced effects as well as preclinical and clinical data that indicate adjuvant cytokine therapies may hold much promise in improving anti-tumor immunity. Further studies on optimal synergistic combinations, timing, duration and additional adjuvant therapies are required to realize the full potential of cytokines as immunotherapeutic agents. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561689     DOI: 10.1016/j.tips.2010.05.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  16 in total

1.  Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein.

Authors:  Yuri Kheifetz; Moran Elishmereni; Zvia Agur
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-09-18       Impact factor: 2.745

2.  Cetuximab-mediated tumor regression depends on innate and adaptive immune responses.

Authors:  Xuanming Yang; Xunmin Zhang; Eric D Mortenson; Olga Radkevich-Brown; Yang Wang; Yang-Xin Fu
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

3.  Staphylococcal enterotoxin B/texosomes as a candidate for breast cancer immunotherapy.

Authors:  Abbas Ali Imani Fooladi; Raheleh Halabian; Mehdi Mahdavi; Mohsen Amin; Hamideh Mahmoodzadeh Hosseini
Journal:  Tumour Biol       Date:  2015-08-06

Review 4.  Materials from peptide assembly: towards the treatment of cancer and transmittable disease.

Authors:  Monica C Branco; Dina M Sigano; Joel P Schneider
Journal:  Curr Opin Chem Biol       Date:  2011-04-18       Impact factor: 8.822

5.  Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors.

Authors:  Ashok D Bandaranayake; Colin Correnti; Byoung Y Ryu; Michelle Brault; Roland K Strong; David J Rawlings
Journal:  Nucleic Acids Res       Date:  2011-09-12       Impact factor: 16.971

6.  Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.

Authors:  Marcus O Butler; Osamu Imataki; Yoshihiro Yamashita; Makito Tanaka; Sascha Ansén; Alla Berezovskaya; Genita Metzler; Matthew I Milstein; Mary M Mooney; Andrew P Murray; Hiroyuki Mano; Lee M Nadler; Naoto Hirano
Journal:  PLoS One       Date:  2012-01-12       Impact factor: 3.240

7.  Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1.

Authors:  Mingrong Cheng; Kangkang Zhi; Xiaoyan Gao; Bing He; Yingchun Li; Jiang Han; Zhiping Zhang; Yan Wu
Journal:  Mol Cancer       Date:  2013-12-18       Impact factor: 27.401

Review 8.  Beyond immune checkpoint blockade: emerging immunological strategies.

Authors:  Shawn P Kubli; Thorsten Berger; Daniel V Araujo; Lillian L Siu; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2021-03-08       Impact factor: 84.694

Review 9.  Insights into cytokine-receptor interactions from cytokine engineering.

Authors:  Jamie B Spangler; Ignacio Moraga; Juan L Mendoza; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

Review 10.  Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer.

Authors:  Ángela Marrugal; Laura Ojeda; Luis Paz-Ares; Sonia Molina-Pinelo; Irene Ferrer
Journal:  Dis Markers       Date:  2016-06-30       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.